openPR Logo
Press release

Cardiometabolic Disease Market - Survey On Potential Players 2025 | Cardax Pharmaceuticals, Inc., Abeille Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L

05-21-2019 02:00 PM CET | Health & Medicine

Press release from: TMR Research

TMR Research

TMR Research

Global Cardiometabolic Disease Market: Snapshot

The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where obesity is on the rise. Rapid urbanization and introduction of public transport that are reduced the obligatory exercise has led to sedentary lifestyles, thereby increasing the risk of lifestyle diseases such as type 2 diabetes. Unfortunately, CMS is on the rise amongst children due to reduced exercise and increasing consumption of fatty food items.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=73

The rate that which the incidence of cardiometabolic disease is growing across the world it is estimated to impact both the developed and developing regions. Those suffering with diabetes and hypertension remain at a higher risk of this condition and thus an interest in these diseases is justifiable. The increasing investments in research and development of treatments of this condition are expected to favor market growth. Additionally, the rise in the rate of obesity is also likely to make cardiometabolic disease a pandemic across the world.

The collective impact of cardiometabolic disease as seen on various dysfunctions of the body is expected to be a major threat for the mankind in the foreseeable future. In the wake of these facts, the disease offers a unique opportunity for several leading players to take serious interest in collaborating their resources and knowledge to develop drugs, therapies, and solutions to fight the destructive disease.

Global Cardiometabolic Market: Overview

Cardiometabolic disease, commonly known as Reaven’s syndrome, is characterized by a group of abnormalities and symptoms that include abdominal obesity, high-blood pressure, poor cholesterol profile (LDL), dyslipidemia (high serum triglycerides), and high plasma glucose. Individuals suffering from cardiometabolic syndrome are prone to a number of diseases such as type 2 diabetes, coronary artery disease (CAD), cardiovascular disease (CVD), stroke, heart failure, and hypertension. Both genetic and environmental conditions can be responsible for the development of cardiometabolic diseases. Various symptoms related to cardiometabolic diseases include central obesity or apple-shaped adiposity, high blood pressure, fatty liver, sleep apnea, erectile dysfunction, and polycystic ovarian syndrome.

Global Cardiometabolic Market: Key Segmentations

Based on the treatments, the global cardiometabolic disease market can be segmented into ACE inhibitors, diuretics, Glucophage, and liposuctions. Angiotensin-converting-enzyme (ACE) inhibitors are a group of drugs, primarily used for the treatment of hypertension and heart failures. They help reduce blood vessel tension and buildup of excess blood volume, thereby lowering the overall blood pressure. Perindopril, lisinopril, ramipril are some of the common ACE inhibitors used today. Diuretics are a group of drugs used to treat heart failure and hypertension, liver cirrhosis, and certain kidney diseases. Diuretics such as bulimics are used by patients to reduce excess weight. A drug named Metformin – a common Glucophage – is used to treat individuals with type 2 diabetes and can also prevent the onset of diabetes in people prone to similar metabolic diseases. The global cardiometabolic disease market also includes the two commercial weight loss pharmacotherapies: orlistat (Xenical) and sibutramine (Meridia).

Patients suffering from high fat deposition are often suggested to opt for an abdominal liposuction, thereby temporarily solving the overweight issue. Apart from the therapeutic drug treatments, proponents of the global cardiometabolic disease market are also promoting the idea that consumers live a healthier lifestyle with diet and exercise.

Global Cardiometabolic Market: Regional Analysis

The global cardiometabolic disease market can be regionally segmented into North America, Europe, Asia-Pacific and the rest of the world. Of all key regions, North America held the leading share in the global cardiometabolic disease market followed by Europe, in 2016. The major factors attributed to the market’s growth in these regions are the increasing epidemic and a growing uptake of unhealthy diets and a largely sedentary lifestyle. According to a survey, so far, 32% of the population in the U.S. was affected by metabolic syndrome, 25% in Europe and Latin America, and there is a continuous rise of metabolic diseases in the developing economies of Asia Pacific. Asia Pacific is likely to be a highly lucrative market for the growth of cardiometabolic disease treatments. Furthermore, the demand for advanced and sophisticated therapeutic treatments is also likely to fuel the global cardiometabolic disease market in the coming years.

Global Cardiometabolic Market: Companies Mentioned in the Report

Some of the leading players of the global Cardiometabolic Disease Market for 2016 were Torrent Pharmaceutical Ltd., Cardax Pharmaceuticals, Inc., Abeille Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L., Spherix Incorporated, and Indus Biotech Private Limited.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=73

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiometabolic Disease Market - Survey On Potential Players 2025 | Cardax Pharmaceuticals, Inc., Abeille Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L here

News-ID: 1747475 • Views:

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation

All 5 Releases


More Releases for Cardiometabolic

Cardiometabolic Disease Market Challenges and Key Players 2025
Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where
Cardiometabolic Drug Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Cardiometabolic Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Cardiometabolic Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Cardiometabolic Disease Market Expert Analyst Report Forecasted 2025
Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where
Cardiometabolic Disease Market Expected to Grow upto 2025
Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where
Cardiometabolic Disease Market - Key Segmentations and Forecast 2017 - 2025
Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where
Cardiometabolic Disease Market - Overview Of Industry Analysis & Forecast 2017 - …
Global Cardiometabolic Disease Market: Snapshot The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years. The high incidence of type 2 diabetes mellitus due to changing lifestyles, genetic predisposition, and obesity have collectively increased the risk of cardiometabolic diseases amongst the global population. The incidence of these cluster of diseases finally leading to cardiometabolic syndrome is expected to be high in developed countries, where